761 related articles for article (PubMed ID: 25522392)
1. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
[TBL] [Abstract][Full Text] [Related]
2. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Jentsch JD; Redmond DE; Elsworth JD; Taylor JR; Youngren KD; Roth RH
Science; 1997 Aug; 277(5328):953-5. PubMed ID: 9252326
[TBL] [Abstract][Full Text] [Related]
3. Loss of asymmetric spine synapses in dorsolateral prefrontal cortex of cognitively impaired phencyclidine-treated monkeys.
Elsworth JD; Hajszan T; Leranth C; Roth RH
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1411-5. PubMed ID: 21733230
[TBL] [Abstract][Full Text] [Related]
4. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.
Elsworth JD; Jentsch JD; Morrow BA; Redmond DE; Roth RH
Neuropsychopharmacology; 2008 Feb; 33(3):491-6. PubMed ID: 17507917
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia clues from monkeys.
Pennisi E
Science; 1997 Aug; 277(5328):900. PubMed ID: 9281070
[No Abstract] [Full Text] [Related]
6. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
McLean SL; Harte MK; Neill JC; Young AM
J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905
[TBL] [Abstract][Full Text] [Related]
7. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
8. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.
Castner SA; Goldman-Rakic PS; Williams GV
Psychopharmacology (Berl); 2004 Jun; 174(1):111-25. PubMed ID: 15205882
[TBL] [Abstract][Full Text] [Related]
9. Low circulating levels of bisphenol-A induce cognitive deficits and loss of asymmetric spine synapses in dorsolateral prefrontal cortex and hippocampus of adult male monkeys.
Elsworth JD; Jentsch JD; Groman SM; Roth RH; Redmond ED; Leranth C
J Comp Neurol; 2015 Jun; 523(8):1248-57. PubMed ID: 25557059
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex.
Castner SA; Vosler PS; Goldman-Rakic PS
Biol Psychiatry; 2005 Apr; 57(7):743-51. PubMed ID: 15820231
[TBL] [Abstract][Full Text] [Related]
11. Loss of asymmetric spine synapses in prefrontal cortex of motor-asymptomatic, dopamine-depleted, cognitively impaired MPTP-treated monkeys.
Elsworth JD; Leranth C; Redmond DE; Roth RH
Int J Neuropsychopharmacol; 2013 May; 16(4):905-12. PubMed ID: 22947206
[TBL] [Abstract][Full Text] [Related]
12. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
Tanaka S
Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
[TBL] [Abstract][Full Text] [Related]
14. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
[TBL] [Abstract][Full Text] [Related]
15. Ibotenic acid induced lesions impair the modulation of dendritic spine plasticity in the prefrontal cortex and amygdala, a phenomenon that underlies working memory and social behavior.
Martínez-Torres NI; Vázquez-Hernández N; Martín-Amaya-Barajas FL; Flores-Soto M; González-Burgos I
Eur J Pharmacol; 2021 Apr; 896():173883. PubMed ID: 33513334
[TBL] [Abstract][Full Text] [Related]
16. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.
Goldman-Rakic PS; Castner SA; Svensson TH; Siever LJ; Williams GV
Psychopharmacology (Berl); 2004 Jun; 174(1):3-16. PubMed ID: 15118803
[TBL] [Abstract][Full Text] [Related]
17. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Elsworth JD; Groman SM; Jentsch JD; Valles R; Shahid M; Wong E; Marston H; Roth RH
Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
[TBL] [Abstract][Full Text] [Related]
18. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
[TBL] [Abstract][Full Text] [Related]
19. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.
Jentsch JD; Tran A; Le D; Youngren KD; Roth RH
Neuropsychopharmacology; 1997 Aug; 17(2):92-9. PubMed ID: 9252984
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine-induced loss of asymmetric spine synapses in rodent prefrontal cortex is reversed by acute and chronic treatment with olanzapine.
Elsworth JD; Morrow BA; Hajszan T; Leranth C; Roth RH
Neuropsychopharmacology; 2011 Sep; 36(10):2054-61. PubMed ID: 21677652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
